PharmaShots Weekly Snapshots (November 08, 12, 2021)
Published: Nov 12, 2021 | Tags: Eisai, Lecanemab, P-IIb, Study 201 Study, Alzheimer's Disease, CTAD 2021
Novo Nordisk's Wegovy (semaglutide) Receives CHMP's Recommendation for Approval to Treat Obesity
Published: Nov 12, 2021 | Tags: Novo Nordisk, Wegovy, semaglutide, CHMP, Approval, Obesity
Published: Nov 12, 2021 | Tags: Oncorus, Gaeta, IL-12, Immune Checkpoint Inhibitors, Cancer
Published: Nov 12, 2021 | Tags: Boehringer Ingelheim, Eli Lilly, US, FDA, sNDA, Priority Review, Jardiance, empagliflozin, HFpEF
Celltrion's CT-P59 (regdanvimab) Receives CHMP's Positive Opinion for the Treatment of COVID-19
Published: Nov 12, 2021 | Tags: Celltrion, CT-P59, regdanvimab, CHMP, COVID-19
Organon to Acquire Forendo for ~$954M
Published: Nov 12, 2021 | Tags: Organon, Acquire, Forendo, ~$954M
Secarna Signs Multiple Agreement with Achilles Therapeutics to Develop Optimized T cell Therapies
Published: Nov 11, 2021 | Tags: Secarna, Achilles Therapeutics, Optimized T cell Therapies
Published: Nov 11, 2021 | Tags: Horizon, P-IIb, Trial, HZN-825, Diffuse Cutaneous Systemic Sclerosis
Published: Nov 11, 2021 | Tags: Mustang Bio, Leiden University Medical Centre, Lentiviral Gene Therapy, RAG1 Severe Combined Immunodeficiency
Published: Nov 11, 2021 | Tags: Finch, CP101, P-II, PRISM-EXT Trial, Recurrent C. difficile Infection
Published: Nov 11, 2021 | Tags: I-Mab, Jumpcan, Eftansomatropin Alfa, TJ101, China
Published: Nov 11, 2021 | Tags: Genentech, Novome Biotechnologies, Targets, Inflammatory Bowel Disease
Published: Nov 10, 2021 | Tags: Exelixis, P-III, CONTACT-01 Trial, Cabometyx, cabozantinib, Tecentriq, atezolizumab, Metastatic Non-Small Cell Lung Cancer
Published: Nov 10, 2021 | Tags: Zai Lab, Karuna Therapeutics, KarXT, xanomeline-trospium, Greater China
Published: Nov 10, 2021 | Tags: AbbVie, Rinvoq, upadacitinib) P-III, SELECT-PsA 1, 2, Trials, Active Psoriatic Arthritis, ACR 2021
Published: Nov 10, 2021 | Tags: Blueprint Medicines, Zai Lab, BLU-945, BLU-701, Greater China
Pfizer Signs a Commercialization Arrangement with Biohaven for Rimegepant to Treat Migraine
Published: Nov 10, 2021 | Tags: Pfizer, Biohaven, Rimegepant, Migraine
Coloplast to Acquire Atos Medical for ~$2.49B
Published: Nov 10, 2021 | Tags: Coloplast, Acquire, Atos Medical, ~$2.49B
Published: Nov 9, 2021 | Tags: Amgen, Aimovig, erenumab-aooe, P-lV, Study, Episodic, Chronic Migraine
Published: Nov 9, 2021 | Tags: Novartis, Cosentyx, secukinumab, P-III, JUNIPERA Study, JPsA, ERA, ACR 2021
Kronos Bio Signs a Multi-Year Collaboration with Tempus for Access to its Platform
Published: Nov 9, 2021 | Tags: Kronos Bio, Tempus, Platform, lanraplenib, KB-0742, Cancer Therapeutics
Regeneron Reports Results of REGEN-COV (casirivimab and imdevimab) in P-III Study Against COVID-19
Published: Nov 9, 2021 | Tags: Regeneron, REGEN-COV, casirivimab, imdevimab, P-III, Study, COVID-19
I-Mab Collaborates with Roche Diagnostics to Co-Develop CDx Solutions at the 4th CIIE (Shanghai)
Published: Nov 9, 2021 | Tags: I-Mab, Roche Diagnostics, CDx Solutions, 4th CIIE
Biotech Acquisition Company Entered into a Merger Agreement with Blade Therapeutics
Published: Nov 9, 2021 | Tags: Biotech Acquisition Company, Merger Agreement, Blade Therapeutics
Alcon to Acquire Ivantis for ~$475M
Published: Nov 8, 2021 | Tags: Alcon, Acquire, Ivantis, ~$475M
Published: Nov 8, 2021 | Tags: Boehringer Ingelheim, Eli Lilly, Jardiance, empagliflozin, P-III, EMPEROR-Preserved Trial, HFpEF, ASN Kidney Week 2021
Published: Nov 8, 2021 | Tags: Pfizer, Paxlovid, COVID-19, Antiviral Therapy, P-II/III, EPIC-HR Study, COVID-19
Published: Nov 8, 2021 | Tags: GSK, Daprodustat, P-III, ASCEND Program, Anemia, Chronic Kidney Disease, ASN 2021
Published: Nov 8, 2021 | Tags: Ascletis, Suzhou Alphamab, ASC22, envafolimab, Hepatitis B, Viral Diseases
Published: Nov 8, 2021 | Tags: BMS, Inspirna, Yervoy, ipilimumab, RGX-104, abequolixron, Metastatic Endometrial Cancer
Related post: PharmaShots Weekly Snapshots (November 01, 03, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com